As AIT is the only causal treatment for IgE-mediated allergy, the World Allergy Organization (WAO) recommend AIT can be considered as initial treatment and failure of pharmacotherapy is not an essential prerequisite of the use of AIT [6]. The gene discussed is IGHE; the disease is allergic disease.